NCT03056664 The Role of MSC in the Treatment of Fistulas in Patients With Perianal Crohn's Disease Status UNKNOWN Phase PHASE2/PHASE3
NCT03017014 A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions Status TERMINATED Phase N/A
NCT03010787 A First Time in Human Study in Healthy Volunteers and Patients Status COMPLETED Phase PHASE1
NCT03000296 Autologous Unselected Hematopoietic Stem Cell Transplantation for Refractory Crohn's Disease Status UNKNOWN Phase NA
NCT03000101 Study of the Role of Pomegranate Juice Ellagitannins in the Modulation of Inflammation in Inflammatory Bowel Disease Status COMPLETED Phase NA
NCT02998398 Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital Status COMPLETED Phase N/A
NCT02976129 A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease Status COMPLETED Phase PHASE2
NCT02942511 Predictors Favoring the Role of Exclusive Enteral Nutrition in Active Crohn's Disease Status COMPLETED Phase N/A
NCT02930564 The Challenge Study: A Dietary Personalization Protocol for Patients With Crohn's Disease and Deep Remission Status TERMINATED Phase NA
NCT02926300 Long-term Safety and Efficacy of FURESTEM-CD Inj. in Patients With Moderately Active Crohn's Disease(CD) Status UNKNOWN Phase N/A
NCT02914600 Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease Status TERMINATED Phase PHASE3
NCT02914561 Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease Status COMPLETED Phase PHASE3
NCT02913508 Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease Status WITHDRAWN Phase PHASE2
NCT02896985 Observational Study Evaluating the Effectiveness of Drug Concentration to Predict the Recapture of Response in Crohn's Disease Patients With Loss of Response ( PRADA ) Status COMPLETED Phase N/A
NCT02891226 A Study of Mirikizumab (LY3074828) in Participants With Active Crohn's Disease Status COMPLETED Phase PHASE2
NCT02883452 A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis Status COMPLETED Phase PHASE1